Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symptom Evaluation and Quantification for Unified Outcomes and Individualized Assessment: Pivotal Clinical Validation Phase

NCT07279038 is registered in ClinicalTrials.gov with Deliberate Solutions Inc. as lead sponsor.

NCT NCT07279038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07279038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symptom Evaluation and Quantification for Unified Outcomes and Individualized Assessment: Pivotal Clinical Validation Phase
Lead sponsor
Deliberate Solutions Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
August 28, 2029
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depression disorders